Literature DB >> 18815940

Identification and characterization of potential impurities of quetiapine fumarate.

Elzbieta U Stolarczyk1, Lukasz Kaczmarek, Kamil Eksanow, Marek Kubiszewski, Magdalena Glice, Andrzej Kutner.   

Abstract

Seven potential impurities, including by-products, starting materials and intermediates were identified in pharmaceutical substance quetiapine fumarate and characterized by spectroscopic methods (MS, IR, NMR). Based on these methods the structures of the impurities were assigned or confirmed as: impurity I: 2-(phenylthio)aniline; impurity II: phenyl N-[2-(phenylthio)phenyl]carbamate; impurity III: N,N'-bis[2-(phenylthio) phenyl]urea; impurity IV: N-[2-(phenylthio)phenyl]-1-piperazinecarboxamide hydrochloride; impurity V: N,N'-bis[(2-phenylthio)phenyl]-1,4-piperazinedicarboxamide; impurity VI: 11-(1-piperazinyl) dibenzo[b,f][1,4]thiazepine fumarate; impurity VII: 1,4-bis(dibenzo[b,f][1,4] thiazepin-11-yl)piperazine. Structural elucidation of compounds, proposed MS fragmentation pathway and possible ways of formation of the impurities are also discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18815940     DOI: 10.1080/10837450802409388

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  1 in total

1.  Development and validation of a stability indicating RP-UPLC method for determination of quetiapine in pharmaceutical dosage form.

Authors:  Rakshit Kanubhai Trivedi; Mukesh C Patel
Journal:  Sci Pharm       Date:  2011-01-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.